Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VONOPRAZAN vs VOSORITIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VONOPRAZAN vs VOSORITIDE: Safety Overview

Metric VONOPRAZAN VOSORITIDE
Total FAERS Reports 2,019 993
Deaths Reported 73 6
Death Rate 3.6% 0.6%
Hospitalizations 342 116
Average Patient Age 63.6 yrs 6.8 yrs
% Female Patients 65.3% 48.5%
FDA Approval Date Nov 1, 2023 Nov 19, 2021
Manufacturer Phathom Pharmaceuticals Inc. BioMarin Pharmaceutical Inc.
Route ORAL N/A
Marketing Status Prescription Prescription